Northern Trust’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-4,040
| Closed | -$35.1K | – | 4545 |
|
2023
Q1 | $35.1K | Hold |
4,040
| – | – | ﹤0.01% | 4345 |
|
2022
Q4 | $53K | Hold |
4,040
| – | – | ﹤0.01% | 4270 |
|
2022
Q3 | $69K | Hold |
4,040
| – | – | ﹤0.01% | 4229 |
|
2022
Q2 | $44K | Hold |
4,040
| – | – | ﹤0.01% | 4441 |
|
2022
Q1 | $90K | Hold |
4,040
| – | – | ﹤0.01% | 4380 |
|
2021
Q4 | $139K | Buy |
4,040
+446
| +12% | +$15.3K | ﹤0.01% | 4320 |
|
2021
Q3 | $220K | Buy |
3,594
+363
| +11% | +$22.2K | ﹤0.01% | 4133 |
|
2021
Q2 | $252K | Sell |
3,231
-8,720
| -73% | -$680K | ﹤0.01% | 4054 |
|
2021
Q1 | $667K | Sell |
11,951
-901
| -7% | -$50.3K | ﹤0.01% | 3734 |
|
2020
Q4 | $787K | Sell |
12,852
-453
| -3% | -$27.7K | ﹤0.01% | 3600 |
|
2020
Q3 | $1.62M | Buy |
13,305
+983
| +8% | +$120K | ﹤0.01% | 3154 |
|
2020
Q2 | $1.46M | Sell |
12,322
-1,365
| -10% | -$161K | ﹤0.01% | 3197 |
|
2020
Q1 | $725K | Sell |
13,687
-661
| -5% | -$35K | ﹤0.01% | 3343 |
|
2019
Q4 | $780K | Buy |
14,348
+183
| +1% | +$9.95K | ﹤0.01% | 3465 |
|
2019
Q3 | $3.43M | Buy |
14,165
+4,657
| +49% | +$1.13M | ﹤0.01% | 2774 |
|
2019
Q2 | $2.18M | Buy |
9,508
+8,974
| +1,681% | +$2.05M | ﹤0.01% | 3045 |
|
2019
Q1 | $165K | Buy |
+534
| New | +$165K | ﹤0.01% | 3820 |
|